AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Propanc Biopharma, Inc. Director's Dealing 2012

Jul 27, 2012

34906_dirs_2012-07-26_d35c77de-75b9-4da1-8a33-3c974f4425a0.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Propanc Health Group Corp (PPCH)
CIK: 0001517681
Period of Report: 2011-12-16

Reporting Person: Nathanielsz James Andrew (Director, Chief Executive Officer, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	10032261	Indirect